NIVEX TRIAL (GECP 1605): Nivolumab in the Real World: Spanish Expanded Access Program Experience in Pretreated Advanced NSCLC Patients
dc.contributor.author | Rodriguez-Abreu, D. | |
dc.contributor.author | Campillo, J. | |
dc.contributor.author | Grau, F. | |
dc.contributor.author | Carcereny, E. | |
dc.contributor.author | Bernabe, R. | |
dc.contributor.author | Garcia, Y. | |
dc.contributor.author | Artal Cortes, A. | |
dc.contributor.author | Gonzalez Cao, M. | |
dc.contributor.author | Juan, O. | |
dc.contributor.author | Garicano, F. | |
dc.contributor.author | Gil-Bazo, I. | |
dc.contributor.author | Blanco, R. | |
dc.contributor.author | Guillot, M. | |
dc.contributor.author | Provencio, M. | |
dc.contributor.author | Majem, M. | |
dc.contributor.authoraffiliation | [Rodriguez-Abreu, D.] Hosital Insular Gran Canaria, Med Oncol, Las Palmas Gran Canaria, Spain | |
dc.contributor.authoraffiliation | [Campillo, J.] Hosp Virgen Arrixaca, Murcia, Spain | |
dc.contributor.authoraffiliation | [Grau, F.] Hosp Univ Hebron, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Carcereny, E.] Hosp Germans Trias I Pujol, Catalan Inst Oncol, Med Oncol, Badalona, Spain | |
dc.contributor.authoraffiliation | [Bernabe, R.] Hosp Univ Virgen Rocio, Seville, Spain | |
dc.contributor.authoraffiliation | [Garcia, Y.] Corp Sanitaria Parc Tauli, Sabadell, Spain | |
dc.contributor.authoraffiliation | [Artal Cortes, A.] Hosp Univ Miguel Servet, Med Oncol, Zaragoza, Spain | |
dc.contributor.authoraffiliation | [Gonzalez Cao, M.] Hosp Univ Dexeus, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Juan, O.] Hosp Univ La Fe, Valencia, Spain | |
dc.contributor.authoraffiliation | [Garicano, F.] Hosp Galdakao, Galdakao, Spain | |
dc.contributor.authoraffiliation | [Gil-Bazo, I.] Clin Univ Navarra, Pamplona, Spain | |
dc.contributor.authoraffiliation | [Blanco, R.] Consorci Sanitari Terrassa, Terrassa, Spain | |
dc.contributor.authoraffiliation | [Guillot, M.] Hosp Son Espases, Palma De Mallorca, Spain | |
dc.contributor.authoraffiliation | [Provencio, M.] Hosp Puerta Hierro, Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Majem, M.] Hosp Santa Creu I Sant Pau, Barcelona, Spain | |
dc.date.accessioned | 2025-01-07T15:34:24Z | |
dc.date.available | 2025-01-07T15:34:24Z | |
dc.date.issued | 2018-10-01 | |
dc.identifier.doi | 10.1016/j.jtho.2018.08.1467 | |
dc.identifier.essn | 1556-1380 | |
dc.identifier.issn | 1556-0864 | |
dc.identifier.unpaywallURL | http://www.jto.org/article/S1556086418324250/pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/27248 | |
dc.identifier.wosID | 454014503129 | |
dc.issue.number | 10 | |
dc.issue.number | S | |
dc.journal.title | Journal of thoracic oncology | |
dc.journal.titleabbreviation | J. thorac. oncol. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen del Rocío | |
dc.page.number | S827-S827 | |
dc.publisher | Elsevier science inc | |
dc.rights.accessRights | open access | |
dc.subject | real world | |
dc.subject | nivolumab | |
dc.subject | NSCLC | |
dc.title | NIVEX TRIAL (GECP 1605): Nivolumab in the Real World: Spanish Expanded Access Program Experience in Pretreated Advanced NSCLC Patients | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 13 | |
dc.wostype | Meeting Abstract |